NLRX1 and carcinoma: Histopathology analysis also revealed an overall reduced pathology and absence of high grade carcinoma lesions in NLRX1-deficient mice (Fig. 5, E and F), suggesting that NLRX1 deficiency reduces cancer progression in this model.